Robert E Conway is Director of ARCA biopharma, Inc.. Currently has a direct ownership of 50,000 shares of ABIO, which is worth approximately $0. The most recent transaction as insider was on May 12, 2021, when has been sold 10,000 shares (Common Stock) at a price of $3.19 per share, resulting in proceeds of $31,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K
0% 3M change
0% 12M change
Total Value Held $0

ROBERT E CONWAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 12 2021
BUY
Open market or private purchase
$31,900 $3.19 p/Share
10,000 Added 16.67%
50,000 Common Stock
May 05 2021
BUY
Open market or private purchase
$32,300 $3.23 p/Share
10,000 Added 20.0%
40,000 Common Stock
Dec 18 2020
BUY
Open market or private purchase
$41,600 $4.16 p/Share
10,000 Added 25.0%
30,000 Common Stock

Also insider at

ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
REC

Robert E Conway

Director
Seattle, WA

Track Institutional and Insider Activities on ABIO

Follow ARCA biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABIO shares.

Notify only if

Insider Trading

Get notified when an Arca Biopharma, Inc. insider buys or sells ABIO shares.

Notify only if

News

Receive news related to ARCA biopharma, Inc.

Track Activities on ABIO